European Pharmaceutical Review

JANUARY 9, 2024

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

European Pharmaceutical Review

AUGUST 23, 2022

A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.

FDA 92

FDA Food and Drug Administration Pharma Pharmaceutical manufacturing 92

European Pharmaceutical Review

AUGUST 10, 2023

Amidst numerous warning letters distributed by the US Food and Drug Administration (FDA) to pharmaceutical manufacturers in recent months, in July this year, the US regulatory body published its analysis on drug product quality in 2022. Eight FDA warning letters were handed to European companies in 2018.

FDA 84

FDA Food and Drug Administration Media Manufacturing 84

Pharmaceutical Technology

JUNE 23, 2022

National Resilience (San Diego, California) announced on 6 June that it had raised $625m in series D financing, which will be spent in part on continuous manufacturing for biologics. The US House of Representatives separately passed a bill on continuous manufacturing on 19 October last year.

Government 64

Government Manufacturing Food and Drug Administration FDA 64

World of DTC Marketing

DECEMBER 10, 2020

Among the 25 worldwide companies that spend the most on research and development—all more than $5 billion a year—seven are pharmaceutical manufacturers, but eight are automobile or automobile-parts companies with profit margins under 10 percent. years to win FDA approval, at a median cost of $648 million.

Insurance 181

Insurance Pharma Manufacturing Retail 181

Pharma Marketing Network

JUNE 11, 2020

And do that, you interviewed me back in 2015, for the results book. I mean, every aspect of the industry from FDA approvals and regulations to the actual nuts and bolts of marketing and what works and what doesn’t work. If you’re a pharmaceutical company or if you’re an agency or even a consultant.

Pharma 52

Pharma Marketing Media Healthcare 52